重型COVID-19患者常规血液指标的动态变化
本文追踪1例住院26天的重型COVID-19患者的流行病学史、诊疗过程及常规血液指标动态变化。发现入院首周病情加重时WBC、中性粒细胞、淋巴细胞、单核细胞、嗜酸性粒细胞、RBC、血红蛋白、NLR、PLT及PLR均下降,第7天降至最低值,而RDW和CRP维持高位;第8至14天病情改善,上述细胞逐渐回升,CRP快速下降;第20天核酸转阴,嗜酸性粒细胞恢复约在入院后12天,早于其他参数。结论认为常规血液参数动态变化可能有助于判断COVID-19预后和评估疗效。
要点
- 重型COVID-19入院首周WBC、淋巴细胞、PLT等下降,第7天达最低值。
- 嗜酸性粒细胞恢复约在入院后12天,早于其他参数,或有助于判断病情进展。
- 动态监测常规血液参数可能辅助评估COVID-19预后与疗效。
核心结论
- 常规血液参数的动态变化可能有助于判断COVID-19患者的预后和评估治疗效果。
研究设计与样本
- 对1例住院26天的重型COVID-19患者进行流行病学史、诊疗过程及常规血液指标动态变化的密切追踪。
主要发现
- 入院首周病情加重,WBC、中性粒细胞、淋巴细胞、单核细胞、嗜酸性粒细胞、RBC、血红蛋白、NLR、PLT及PLR均下降。
- 入院第7天上述细胞水平降至最低值,而RDW和CRP维持高位。
- 入院第8至14天病情改善,低氧血症纠正并停用机械通气,WBC、中性粒细胞、单核细胞、嗜酸性粒细胞及淋巴细胞逐渐升高,红细胞参数止跌并稳定在一定范围,CRP快速下降。
- 入院第20天核酸检测阴性,WBC、中性粒细胞、CRP、NLR及PLR逐渐下降,单核细胞、淋巴细胞及嗜酸性粒细胞计数升高;RBC和Hb继续下降但RDW逐渐升高,提示造血恢复。
- 入院后10天内单核细胞和嗜酸性粒细胞处于极低水平,嗜酸性粒细胞恢复约在入院后12天,早于其他参数。
临床怎么用
- 对重型COVID-19患者可动态监测常规血液参数,辅助判断病情进展与治疗效果。
- 关注嗜酸性粒细胞的恢复时间,其较其他参数更早回升,可能有助于判断病情进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Novel coronavirus infectious disease (COVID-19) has been spreading worldwide, and tracking laboratory indexes during the diagnosis and treatment of patients with severe COVID-19 can provide a reference for patients in other countries and regions. METHODS: We closely tracked the epidemiological history, diagnosis and treatment process, as well as dynamic changes in routine blood indicators, of a severe COVID-19 patient who was hospitalized for 26 days. RESULTS: Our study found that the patient's condition worsened in the first week after admission, white blood cells (WBCs), neutrophils, lymphocytes, monocytes, eosinophils, red blood cells (RBCs), hemoglobin, neutrophil lymphocyte ratio (NLR), platelets (PLT) and platelet lymphocyte ratio (PLR) decreased. On the 7th day of admission, the levels of these cells decreased to their lowest values, though the red blood cell distribution width (RDW) and C-reactive protein (CRP) level remained at high values. From 8 to 14 days of admission, the patient's condition improved, hypoxemia was corrected, and mechanical ventilation was discontinued. The number of WBCs, neutrophils, monocytes, eosinophils and lymphocytes increased gradually, and the erythrocyte parameters stopped declining and stabilized in a certain range; CRP decreased rapidly. On the 20th day of admission, the nucleic acid test was negative, WBC, neutrophil, CRP, NLR and PLR decreased gradually, and monocyte, lymphocyte, and eosinophil counts increased. Although RBCs and hemoglobin (Hb) levels continued to decrease, RDW gradually increased, indicating the recovery of hematopoiesis. In addition, it should be noted that monocytes and eosinophils were at extremely low levels within 10 days after admission; the recovery time of eosinophils was approximately 12 days after admission, which was earlier than other parameters, which might be of great value in judging the progress of the disease. CONCLUSIONS: Dynamic changes in routine blood parameters might be helpful for the prognosis of COVID-19 patients and evaluation of the treatment effect.
引用
- Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case. Clin Chim Acta. 2020. PMID: 32405079. doi:10.1016/j.cca.2020.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。